Search Results for "Cefoxitin Drug Study"
Original Source: Cefoxitin [APP Pharmaceuticals, LLC]
CEFOXITIN FOR INJECTION, USP
Matching Channels
SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in e...
ETS2101 (dexanabinol) is a synthetic cannabinoid previously studied in trauma patients. Its anti-cancer potential was identified by e-Therapeutics’ network pharmacology platform. This revealed...
Matching News
Alzheimer's drug fails in 1 study, 2nd continues
Pfizer Inc. said Monday that a closely watched experimental Alzheimer's drug failed to slow the disease in one late-stage study, but the drug maker said it will continue to study the drug's effect on...
Study: New Drug May Help Some Asthmatics
A new asthma drug being developed by Sanofi and Regeneron Pharmaceuticals may help patients whose condition is not well controlled by existing medicines, according to the results of a small clinical t...
Vertex CF Drug Shines in Late-Stage Study in Children
Vertex Pharmaceuticals (NASDAQ:VRTX) reported today positive results from an ongoing late-stage study of its cystic fibrosis drug, VX-770, that show that the drug is working about as well in children...
News briefs: setbacks for B-MS hep C drug; Baxter's HyQ
US drug major Bristol-Myers Squibb (NYSE: BMY) has suspended study drug administration in ongoing Phase II study of BMS-986094. The company has suspended study drug administration in an ongoing Phase...
Growing protocol complexity-responsible for longer clinical study times, greater difficulty in recruiting volunteers, and rising drug development costs-is spurring new approaches to optimizing protoco...
Study shows efficacy of new rheumatoid arthritis drug
(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is publish...
Experimental Insomnia Drug Shows Promise
By Amy Norton HealthDay Reporter WEDNESDAY, Nov. 28 (HealthDay News) -- A new insomnia drug helped people get a bit more shut-eye in a lab study, researchers report. The drug, known a...
Pfizer and Janssen’s Alzheimer’s drug fails
Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III trial showed the drug failed to change cognitive and functiona...
Matching PubMed Articles
A Severe Case of Cefoxitin-Induced Immune Hemolytic Anemia.
Drug-induced immune hemolytic anemia is a rare but underdiagnosed and potentially fatal condition. We report a case of severe hemolytic anemia induced by cefoxitin in a 45-year-old woman admitted with...
The Clinical Laboratory Standards Institute recommends that if both cefoxitin and oxacillin are tested against Staphylococcus aureus and either result is measured as resistant, the organism should be...
In vitro studies demonstrate that oxacillin minimal inhibitory concentrations (MICs) of methicillin-resistant S. aureus (MRSA) strains USA300 and 400 decrease in the presence of cefoxitin. The aim of...
The Clinical and Laboratory Standards Institute (CLSI) recommends testing coagulase-negative staphylococci (CoNS) strains to determine resistance against oxacillin by testing for mecA, PBP2a, or with...
Between February 2005 and January 2006 in Srinagarind Hospital, Thailand, 44 from 1730 isolates (2.5%) of Escherichia coli and 8 from 982 isolates (0.8%) of Klebsiella pneumoniae were found to produce...
